| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease?
|
Jenner, Peter
|
|
|
80 |
S1 |
p. S28-S36
|
article
|
| 2 |
Can adenosine A2A receptor antagonists modify motor behavior and dyskinesia in experimental models of Parkinson's disease?
|
Kanda, Tomoyuki
|
|
|
80 |
S1 |
p. S21-S27
|
article
|
| 3 |
Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?
|
Chen, Jiang-Fan
|
|
|
80 |
S1 |
p. S45-S53
|
article
|
| 4 |
Editorial Board
|
|
|
|
80 |
S1 |
p. i
|
article
|
| 5 |
How do adenosine A2A receptors regulate motor function?
|
Mori, Akihisa
|
|
|
80 |
S1 |
p. S13-S20
|
article
|
| 6 |
Introduction
|
LeWitt, Peter A.
|
|
|
80 |
S1 |
p. S1-S2
|
article
|
| 7 |
Pharmacological interactions between adenosine A2A receptor antagonists and different neurotransmitter systems
|
Pinna, Annalisa
|
|
|
80 |
S1 |
p. S37-S44
|
article
|
| 8 |
The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant
|
LeWitt, Peter A.
|
|
|
80 |
S1 |
p. S54-S63
|
article
|
| 9 |
Unmet needs in Parkinson disease: Motor and non-motor
|
LeWitt, Peter A.
|
|
|
80 |
S1 |
p. S7-S12
|
article
|
| 10 |
Why target brain adenosine receptors? A historical perspective
|
Fredholm, Bertil B.
|
|
|
80 |
S1 |
p. S3-S6
|
article
|
Journal description